<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this survey, European physicians who deal with <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> patients gave their opinions about diagnostic work up when they see patients with <z:mp ids='MP_0009732'>ventricular premature beats</z:mp> (<z:mp ids='MP_0009732'>VPBs</z:mp>) or non-sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (NSVT) </plain></SENT>
<SENT sid="1" pm="."><plain>In general, similar work-up regimens were used for these two <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> except for coronary angiography, which was considered by one in four physicians when dealing with NSVT but by almost none for <z:mp ids='MP_0009732'>VPBs</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The majority of physicians believe that it is acceptable to abstain from pharmacological therapy in an asymptomatic patient with <z:mp ids='MP_0009732'>VPBs</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>When considering second-line therapy almost half of the respondents would consider <z:chebi fb="0" ids="2663">amiodarone</z:chebi> in patients with NSVT whereas almost none would when dealing with <z:mp ids='MP_0009732'>VPBs</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>When the effect of therapy was evaluated, its influence on symptoms and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> burden were ranked highest </plain></SENT>
</text></document>